France will ban the advertising of ibuprofen for doses of 400 mg. The objective of this measure is to promote "better education to encourage better use" of these medications.
Paracetamol remains the preferred option : about 600 million boxes sold in 2022, compared to about 34 million boxes of ib uprofen. Europe warns of possible serious harm from the abuse of ibUprofen with codeine. The 'lack' of drugs is entrenched in Spain: these are the medications with problems in recent times.